Min Lu

Min Lu is an accomplished executive in the biotechnology sector, currently serving as Executive Director and Head of Fibrosis at Morphic Therapeutic since November 2017, following progressive roles as Senior Director and Director within the same organization. With a robust background at Merck as Associate Principal Scientist and a previous staff scientist role at Takeda California, Inc., Min Lu has a proven track record in leading fibrosis research and drug discovery efforts. Additional experience includes significant contributions at Pfizer - CovX Biotherapeutics, as well as a solid foundation in metabolic research during time spent as an Assistant Project Scientist and Postdoctoral Fellow at the University of California, San Diego. Early career experience includes practicing as a resident physician at Shanghai Jing-An District Central Hospital. Min Lu earned a PhD in Biomedical Science from the University of California, Riverside, in 2005.